The device giant also reported net sales totaling $739.5 million for the fourth quarter of fiscal year 2012, a 3 percent increase compared to the same quarter last year, as well as an operating loss of $378 million during the fourth quarter of fiscal year 2012, compared to an operating loss of $847.3 million for the same period last year.
More Articles on Biomet:
41 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in June
20 Spine Devices Receive FDA 510(k) Clearance in June
Biomet Closes DePuy Trauma Acquisition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.